<p>Age- and sex-matched male TRAMP (white bars; n = 97), TRAMPJα18<sup>−/−</sup> (black bars; n = 51) and WT mice (gray bars; n = 97) were killed at the indicated week after birth and the anatomy and histology of the UGA was analyzed as indicated in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0008646#s2" target="_blank">Material and Methods</a> section. Animals affected by neuroendocrine tumors were excluded. A, UGA weight (g), expressed as average±SEM, of TRAMP, TRAMPJα18<sup>−/−</sup> and WT mice killed at weeks 6–8 (n = 5, 8 and 19, respectively), 12–16 (n = 16, 17 and 26), 17–24 (n = 30, 15 and 26) and 25–28 (n = 46, 11 and 26), respectively. B, ratio of the weight of UGA and body weight subtracted of the U...
<div><p>(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted versus th...
Rb+/- mice develop a complex spectrum of neuroendocrine tumors on a mixed genetic (129Sv x C57BL/6) ...
<p>Development of foci of cellular alteration (FCA), the proliferating cell nuclear antigen (PCNA)-l...
<p>Kaplan-Maier plot reporting the survival curves of groups of male TRAMP (black squares; n = 21) a...
<p>Time to palpable tumor curves for C57BL/6 TRAMP mice (grey line; n = 42) and TRAMP S100A9<sup>−/−...
<p><b>A.</b> Event-free survival. The y-axis shows the proportion of animals that remain free of an ...
<p>A. Time to palpable tumor curves for C57BL/6 TRAMP mice (black line; n = 18) and TRAMP TLR4<sup>−...
<p>(a) Kaplan-Meier survival curve for TRAMP F1 strains with a significantly increased tumor-associa...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
In our previous work we showed that dietary restriction initiated at puberty reduced prostate cancer...
<p>A) TRAMP-C2 tumor cells grow progressively in adult male mice, with a slower kinetic but complete...
<p>(a). Mice (9–10 months old) were injected with B16 melanoma cells and tumor volumes were determin...
<p>Tumors were dissected and measured. Tumor volumes were calculated by the formula ((π/6)×width<sup...
<p>(A) VCP<sup>R155H/R155H</sup> mice are much smaller and weaker and demonstrate gross abnormalitie...
<p>At 10 weeks of age, MMTV-PyMT mice were treated with 50 mg/kg of mAb AFS98, control rat IgG or PB...
<div><p>(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted versus th...
Rb+/- mice develop a complex spectrum of neuroendocrine tumors on a mixed genetic (129Sv x C57BL/6) ...
<p>Development of foci of cellular alteration (FCA), the proliferating cell nuclear antigen (PCNA)-l...
<p>Kaplan-Maier plot reporting the survival curves of groups of male TRAMP (black squares; n = 21) a...
<p>Time to palpable tumor curves for C57BL/6 TRAMP mice (grey line; n = 42) and TRAMP S100A9<sup>−/−...
<p><b>A.</b> Event-free survival. The y-axis shows the proportion of animals that remain free of an ...
<p>A. Time to palpable tumor curves for C57BL/6 TRAMP mice (black line; n = 18) and TRAMP TLR4<sup>−...
<p>(a) Kaplan-Meier survival curve for TRAMP F1 strains with a significantly increased tumor-associa...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
In our previous work we showed that dietary restriction initiated at puberty reduced prostate cancer...
<p>A) TRAMP-C2 tumor cells grow progressively in adult male mice, with a slower kinetic but complete...
<p>(a). Mice (9–10 months old) were injected with B16 melanoma cells and tumor volumes were determin...
<p>Tumors were dissected and measured. Tumor volumes were calculated by the formula ((π/6)×width<sup...
<p>(A) VCP<sup>R155H/R155H</sup> mice are much smaller and weaker and demonstrate gross abnormalitie...
<p>At 10 weeks of age, MMTV-PyMT mice were treated with 50 mg/kg of mAb AFS98, control rat IgG or PB...
<div><p>(A) Average number of papillomas (more than 2 mm in diameter) per mouse is plotted versus th...
Rb+/- mice develop a complex spectrum of neuroendocrine tumors on a mixed genetic (129Sv x C57BL/6) ...
<p>Development of foci of cellular alteration (FCA), the proliferating cell nuclear antigen (PCNA)-l...